LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

Inicio・Lista de Acciones・Geron Corp

Geron Corp

Cerrado

SectorSanidad

1.56 -0.64

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.56

Máximo

1.69

Métricas clave
By Trading Economics
Ingresos	-10M -29M
Ventas	788K 48M
Margen de beneficios	-60.11
Empleados	258
EBITDA	-14M -24M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+107.01% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-124M 1B
Apertura anterior	2.2
Cierre anterior	1.56

Geron Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 may 2026, 23:41 UTC

Ganancias

Arm Holdings Lacks Supply to Meet Roaring Demand for New Chips -- Update

6 may 2026, 21:40 UTC

Ganancias

Nutrien Logs Higher Profit, Sales Growth in 1Q

6 may 2026, 23:47 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

6 may 2026, 23:34 UTC

Charlas de Mercado

Gold Prices Steady, Supported by Lower U.S. Treasury Yields -- Market Talk

6 may 2026, 23:13 UTC

Ganancias

Kakao 1Q Net Profit Beat FactSet-Compiled Consensus

6 may 2026, 23:13 UTC

Ganancias

Kakao 1Q Net KRW226.84B Vs. Net KRW200.33B >035720.SE

6 may 2026, 23:12 UTC

Ganancias

Kakao 1Q Oper Pft KRW211.40B Vs. Pft KRW105.40B >035720.SE

6 may 2026, 23:11 UTC

Ganancias

Kakao 1Q Rev KRW1.942T Vs. KRW1.864T >035720.SE

6 may 2026, 23:11 UTC

Ganancias

United Overseas Bank's CEO: Low Single-Digit Loan Growth Outlook for 2026 >U11.SG

6 may 2026, 23:11 UTC

Ganancias

United Overseas Bank's CEO: 2026 Outlook for Total Credit Costs at 25-30 Basis Points >U11.SG

6 may 2026, 23:11 UTC

Ganancias

United Overseas Bank's CEO: Low Single-Digit Operating Cost Growth Outlook for 2026>U11.SG

6 may 2026, 23:11 UTC

Ganancias

United Overseas Bank's CEO: 2026 Outlook for Full-Year NIM of 1.75%-1.80% >U11.SG

6 may 2026, 23:11 UTC

Ganancias

United Overseas Bank's CEO: High Single-Digit Fee Growth Outlook for 2026 >U11.SG

6 may 2026, 23:07 UTC

Ganancias

United Overseas Bank: 1Q Net Profit Decline Reflects Softer Operating Environment >U11.SG

6 may 2026, 23:06 UTC

Ganancias

United Overseas Bank 1Q Net Fee Income S$637M Vs. S$694M >U11.SG

6 may 2026, 23:06 UTC

Ganancias

United Overseas Bank 1Q Net Interest Income S$2.32B Vs. S$2.41B >U11.SG

6 may 2026, 23:05 UTC

Ganancias

United Overseas Bank 1Q Net S$1.44B Vs. Net S$1.49B >U11.SG

6 may 2026, 23:04 UTC

Ganancias

United Overseas Bank 1Q Total Income S$3.42B Vs. S$3.66B >U11.SG

6 may 2026, 22:50 UTC

Ganancias

Sarepta Stock Sinks on Earnings Beat. Elevidys Demand Faces a Reality Check. -- Barrons.com

6 may 2026, 22:25 UTC

Charlas de Mercado

Canada's Public Finances on Sustainable Path, BOC's Macklem Says -- Market Talk

6 may 2026, 22:11 UTC

Ganancias

Taseko Mines Ltd. 1Q Adj EPS C$0.08 >TKO.LN

6 may 2026, 22:11 UTC

Ganancias

Taseko Mines Ltd. 1Q EPS C$0.05 >TKO.LN

6 may 2026, 22:05 UTC

Charlas de Mercado

Updated Govt Fiscal Plan Won't Have Sizable Impact on BOC Outlook -- Market Talk

6 may 2026, 21:58 UTC

Ganancias

Arm Stock Takes Wild Ride After Earnings. Demand Might Be Too Strong to Meet. -- Barrons.com

6 may 2026, 21:47 UTC

Charlas de Mercado

Ganancias

Costco Posts 13% Sales Growth in April -- Market Talk

6 may 2026, 21:46 UTC

Ganancias

IonQ Doubles Down on Nvidia Comparison. Why the Stock Is Falling After Blowout Earnings. -- Barrons.com

6 may 2026, 21:40 UTC

Ganancias

Arm Stock Takes Wild Ride After Earnings. Demand Might Be Too Strong to Meet. -- Barrons.com

6 may 2026, 21:35 UTC

Charlas de Mercado

BOC's Macklem Defends Warning About Rate Hikes to Fight Inflation -- Market Talk

6 may 2026, 21:32 UTC

Acciones populares

Stocks to Watch Wednesday Recap: Advanced Micro Devices, Flutter, Disney, Uber -- WSJ

6 may 2026, 21:29 UTC

Ganancias

Fastly Stock Tumbles. An Earnings Beat Pauses a Monster Rally. -- Barrons.com

Comparación entre iguales

Cambio de precio

Geron Corp previsión

Precio Objetivo

By TipRanks

107.01% repunte

Estimación a 12 Meses

Media 3.25 USD 107.01%

Máximo 5 USD

Mínimo 1 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Geron Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Geron Corp Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.